Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ad-hoc News: CEOTRONICS AG (EQS) +++ CEOTRONICS Aktie +3,90%

MEDICOVER Aktie

 >MEDICOVER Aktienkurs 
19.78 EUR    (Tradegate)
Ask: 19.86 EUR / 160 Stück
Bid: 19.7 EUR / 160 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
MEDICOVER Aktie über LYNX handeln
>MEDICOVER Performance
1 Woche: -4,5%
1 Monat: -9,8%
3 Monate: -17,7%
6 Monate: -10,6%
1 Jahr: +21,6%
laufendes Jahr: +18,0%
>MEDICOVER Aktie
Name:  MEDICOVER AB
Land:  Schweden
Sektor:  Gesundheit
ISIN/ Wkn:  SE0009778848 / A2DRQV
Symbol/ Ticker:  5M0B (Frankfurt)
Kürzel:  FRA:5M0B, ETR:5M0B, 5M0B:GR
Index:  -
Webseite:  https://www.medicover.com..
Profil:  Medicover AB is a renowned provider of healthcare ..
>Volltext..
Marktkapitalisierung:  3069.31 Mio. EUR
Unternehmenswert:  4385.52 Mio. EUR
Umsatz:  2345.64 Mio. EUR
EBITDA:  360.54 Mio. EUR
Nettogewinn:  67.73 Mio. EUR
Gewinn je Aktie:  0.45 EUR
Schulden:  1385.4 Mio. EUR
Liquide Mittel:  82.44 Mio. EUR
Operativer Cashflow:  251.9 Mio. EUR
Bargeldquote:  0.14
Umsatzwachstum:  16.78%
Gewinnwachstum:  241.93%
Dividende je Aktie:  0.15 EUR
Dividendenrendite:  0.74%
Dividendenschätzung:  0.74%
Div. Historie:  30.04.25 - 0.15€
29.04.24 - 0.12€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  MEDICOVER
Letzte Datenerhebung:  17.12.25
>MEDICOVER Kennzahlen
Aktien/ Unternehmen:
Aktien: 74.43 Mio. St.
Frei handelbar: 87.44%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 47256
Umsatz/Mitarb.: 0.04 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 23.42%
Bewertung:
KGV: 46.75
KGV lG: 38.3
KUV: 1.35
KBV: 6.26
PEG-Ratio: 0.2
EV/EBITDA: 12.16
Rentabilität:
Bruttomarge: 22.99%
Gewinnmarge: 2.89%
Operative Marge: 6.32%
Managementeffizenz:
Gesamtkaprendite: 3.06%
Eigenkaprendite: 13.34%
>MEDICOVER Peer Group

Es sind 149 Aktien bekannt.
 
05.11.25 - 09:01
Medicover: Umsatzwachstum im Q3 verfehlt die Erwartungen (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
31.01.25 - 10:01
Invitation to Medicover′s results presentation for Q4 2024 (Cision)
 
Medicover's (MCOV B) year-end and Q4 report 2024 will be published on 12 February at 07.45 CET. The Company will hold a conference call (in English) for media, financial analysts and investors at 09.30 CET. The report will be presented by CEO Fredrik Rågmark and CFO Anand Patel, followed by a Q&A session. Shortly before the webcast, presentation slides will be available on medicover.com (https://www.medicover.com/financial-information). If you wish to participate via audiocast please use the link below. Audiocast (https://medicover.events.inderes.com/q4-report-2024/register)...
20.12.24 - 16:30
Medicover to exit Hungary fully (Cision)
 
Medicover has decided to exit the Hungarian market and disposes of its insurance operations in Hungary. Since 2013, Medicover has only operated its health insurance business in Hungary having no clinics or health provision activities. Medicover will also terminate its brand licensing used with Hungarian partner clinics providing services to members. The health insurance business will be transferred to another Hungarian health insurer and a transfer process has already been initiated in collaboration with the relevant authorities. The transition is expected to take approximately six...
20.12.24 - 11:18
Medicover′s Social Finance Investor Report is now published (Cision)
 
Medicover has released its Social Finance Investor Report for 2024. The social finance framework was launched in 2021 and in connection with the launch €277m was raised in German schuldschein debt. The social financing framework is a use-of-proceeds structure and aims to contribute to the World Bank's Universal Health Coverage goals, ensuring that people have access to essential healthcare services. Lack of health infrastructure is one of the global development challenges and improving and increasing access for communities to affordable healthcare requires significant investments in...
10.12.24 - 22:01
Medicover to evaluate a potential separate listing in india (Cision)
 
The board of directors of Medicover AB (Publ) has today decided to evaluate the opportunity to list the Indian hospital subsidiary in India over the coming 12-24 months to further support its growth ambitions in the fast-growing Indian market. Medicover Hospitals India operates 23 hospitals and 2 cancer centres in four states (Andra Pradesh, Karnataka, Maharashtra and Telangana). Revenue in India for the last twelve months was €196.9 million at the end of Q3 2024. Medicover plans to open two new hospitals in 2025 and early 2026. If a listing takes place, the process is estimated to take...
03.12.24 - 10:32
Deutsche Bank starts Medicover with ′buy′ on stable revenue, growth in Europe and India (Reuters EN)
 
BUZZ-Deutsche Bank starts Medicover with 'buy' on stable revenue, growth in Europe and India ** Shares of Swedish healthcare provider Medicover MCOVb.ST rise 0.9% to SEK 182.2 ** Deutsche Bank initiates coverage with a "buy" and TP of SEK 210, citing stable revenues, Central European growth, and strategies to counter German regulatory risks ** Says...
12.11.24 - 16:30
Frontage Laboratories, Inc.: Frontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing Services (Accesswire)
 
EXTON, PA / ACCESSWIRE / November 12, 2024 / Frontage Laboratories, Inc., a global CRO, and Medicover Integrated Clinical Services (MICS), part of Medicover, an international healthcare and diagnos......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Mensch ward zum Tun und nicht zum Vernünfteln erschaffen. Aber eben deswegen, weil er nicht dazu erschaffen ward, hängt er diesem mehr als jenem nach. - Gotthold Ephraim Lessing
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!